FBC
AEGR

Fairfield, Bush & Co’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History

Fairfield, Bush & Co’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,885
Closed -$226K – 169
2014
Q1 		$226K Buy
+4,885
New +$226K 0.11% 98
2013
Q4 		– Sell
-2,125
Closed -$182K – 275
2013
Q3 		$182K Sell
2,125
-2,706
-56% -$232K 0.06% 147
2013
Q2 		$306K Buy
+4,831
New +$306K 0.16% 108